Call For Papers
The ICMEDD aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Metabolism, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Metabolic enzymes in drug discovery
- Targeting metabolic pathways in cancer therapy
- Role of enzymes in drug metabolism
- Innovations in enzyme-based therapeutics
- Biotechnology applications in enzyme development
- Enzyme inhibitors in metabolic diseases
- Metabolic profiling for drug development
- Enzyme engineering for pharmaceutical applications
- Natural products as enzyme inhibitors
- Clinical trials of enzyme-based drugs
- Enzyme replacement therapies for metabolic disorders
- Regulatory challenges in enzyme therapeutics
- Metabolic enzymes in personalized medicine
- High-throughput screening of enzymes
- Enzyme kinetics and drug interactions
- Synthetic biology in enzyme production
- Enzyme stability and formulation strategies
- Emerging trends in enzyme research
- Enzymatic assays in drug development
- Future perspectives on metabolic enzymes
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.